| Epigenetics and oxidative stress in aging A Guillaumet-Adkins, Y Yañez, MD Peris-Diaz, I Calabria, ... Oxidative medicine and cellular longevity 2017, 2017 | 173 | 2017 |
| Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor B Hämmerle, Y Yañez, S Palanca, A Cañete, DJ Burks, V Castel, ... PloS one 8 (10), e76761, 2013 | 67 | 2013 |
| Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease E Grau, F Martinez, C Orellana, A Canete, Y Yañez, S Oltra, R Noguera, ... Molecular carcinogenesis 50 (3), 153-162, 2011 | 55 | 2011 |
| Exosomal microRNAs from longitudinal liquid biopsies for the prediction of response to induction chemotherapy in high-risk neuroblastoma patients: a proof of concept SIOPEN study‖ M Morini, D Cangelosi, D Segalerba, D Marimpietri, F Raggi, A Castellano, ... Cancers 11 (10), 1476, 2019 | 50 | 2019 |
| Neuroblastoma in adolescents: genetic and clinical characterisation V Castel, E Villamón, A Cañete, S Navarro, A Ruiz, C Melero, A Herrero, ... Clinical and Translational Oncology 12, 49-54, 2010 | 41 | 2010 |
| Two independent epigenetic biomarkers predict survival in neuroblastoma Y Yáñez, E Grau, VC Rodríguez-Cortez, D Hervás, E Vidal, R Noguera, ... Clinical epigenetics 7, 1-14, 2015 | 34 | 2015 |
| Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma Y Yáñez, E Grau, S Oltra, A Cañete, F Martínez, C Orellana, R Noguera, ... Journal of cancer research and clinical oncology 137, 1263-1272, 2011 | 31 | 2011 |
| TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients Y Yáñez, D Hervás, E Grau, S Oltra, G Pérez, S Palanca, M Bermúdez, ... Journal of cancer research and clinical oncology 142, 573-580, 2016 | 29 | 2016 |
| Li–Fraumeni syndrome heterogeneity P Gargallo, Y Yáñez, V Segura, A Juan, B Torres, J Balaguer, S Oltra, ... Clinical and Translational Oncology 22, 978-988, 2020 | 28 | 2020 |
| Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients E Grau, F Martinez, C Orellana, A Canete, Y Yanez, S Oltra, R Noguera, ... Journal of cancer research and clinical oncology 136, 1415-1421, 2010 | 27 | 2010 |
| Clinical features of neuroblastoma with 11q deletion: an increase in relapse probabilities in localized and 4S stages A Juan Ribelles, S Barberá, Y Yáñez, P Gargallo, V Segura, B Juan, ... Scientific reports 9 (1), 13806, 2019 | 24 | 2019 |
| Ewing sarcoma predisposition P Gargallo, Y Yáñez, A Juan, V Segura, J Balaguer, B Torres, S Oltra, ... Pathology & Oncology Research 26, 2057-2066, 2020 | 21 | 2020 |
| Pharmacogenetics implementation in the clinics: information and guidelines for germline variants G Olivera, L Sendra, MJ Herrero, P Berlanga, P Gargallo, Y Yáñez, ... Cancer Drug Resistance 2 (1), 53, 2019 | 18 | 2019 |
| Precision medicine in Ewing sarcoma: a translational point of view P Gargallo, A Juan, Y Yáñez, S Dolz, V Segura, V Castel, A Cañete Clinical and Translational Oncology 22, 1440-1454, 2020 | 17 | 2020 |
| TIAM1 variants improve clinical outcome in neuroblastoma E Sanmartín, Y Yáñez, V Fornés-Ferrer, JL Zugaza, A Cañete, V Castel, ... Oncotarget 8 (28), 45286, 2017 | 16 | 2017 |
| Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT‐qPCR—A strategy for improving the safety of fertility restoration V Grèze, F Brugnon, F Chambon, P Halle, M Canis, C Amiot, AS Grémeau, ... Pediatric Blood & Cancer 64 (5), e26287, 2017 | 15 | 2017 |
| Germline predisposition to pediatric cancer, from next generation sequencing to medical care P Gargallo, S Oltra, Y Yáñez, A Juan-Ribelles, I Calabria, V Segura, ... Cancers 13 (21), 5339, 2021 | 11 | 2021 |
| Next-generation DNA sequencing-based gene panel for diagnosis and genetic risk stratification in onco-hematology P Gargallo, M Molero, C Bilbao, R Stuckey, E Carrillo-Cruz, L Hermosín, ... Cancers 14 (8), 1986, 2022 | 9 | 2022 |
| New prognostic markers in neuroblastoma S Navarro, M Piqueras, E Villamón, Y Yáñez, J Balaguer, A Cañete, ... Expert Opinion on Medical Diagnostics 6 (6), 555-567, 2012 | 9 | 2012 |
| MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients GG Olivera, Y Yáñez, P Gargallo, L Sendra, SF Aliño, V Segura, MÁ Sanz, ... International Journal of Molecular Sciences 21 (8), 2714, 2020 | 8 | 2020 |
